Uveal Melanoma Latest Advances
Find the Latest Research About Uveal Melanoma
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7024 publications
Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 28, 2026
Uveal melanoma: innovations in therapy, prognosis, and imaging.
Journal: Expert review of anticancer therapy
Published: October 27, 2026
Bispecific T-cell engagers beyond hematology: Expanding uses in solid tumors.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 24, 2026
Erratum in: Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.
Journal: Investigative ophthalmology & visual science
Published: October 23, 2026
Current Practices and Future Perspective in Radiotherapy for Uveal Melanoma: Overcoming Hypoxia-Mediated Radiation Resistance With Oxygen Nanocarriers.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: October 22, 2026
Association of Age With Gene Expression Profile (GEP) Class and Preferentially Expressed Antigen in Melanoma (PRAME) Expression Status in Uveal Melanoma.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: October 22, 2026
Cytopathology and Prognostic Accuracy of 15-GEP/PRAME: The Collaborative Ocular Oncology Group Study 2.
Journal: JAMA ophthalmology
Published: October 15, 2026
Pretreatment MRI radiomics for predicting recurrence and metastasis after hypofractionated stereotactic radiosurgery in uveal melanoma.
Journal: European journal of ophthalmology
Published: October 12, 2026
BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression.
Journal: bioRxiv : the preprint server for biology
Published: October 10, 2026
Tebentafusp desensitization in an adult with metastatic uveal melanoma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 09, 2026
Outcomes of CD20-targeting CAR T-cell therapy in patients with advanced melanoma: MB-CART20.1 Melanoma phase I trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 06, 2026
Last Updated: 11/08/2026